Eric Rougemond

Eric Rougemond is the Chief Executive Officer of Laboratoire Aguettant, PROMISE Advanced Proteomics, and was previously the CEO of PX'Therapeutics. Prior to these roles, Eric held various leadership positions in EUSA Pharma, including Vice President for multiple regions. With a background in medical and clinical affairs, Eric has extensive experience in oncology, neurology, critical care, and orphan drugs. With a strong focus on P&L management and business development, Eric has also managed teams and partnerships in his various roles. Having obtained a Degree in Management of Pharmaceutical Industry and a Doctor of Medicine degree, Eric Rougemond has a well-rounded background in the pharmaceutical industry.